TABLE 3.
Rates of adverse events, compliance and symptom improvement (n/N, %)
BA group | TF group | P value | |
---|---|---|---|
Overall adverse events | 61/329 (18.5) | 86/329 (26.1) | 0.024 |
Severe adverse events | 3/329 (0.9) | 4/329 (1.2) | 1.000 |
Compliance rate | 305/329 (92.7) | 296/329 (90.0) | 0.267 |
2‐week symptom improvement | 196/283 (69.3) | 166/266 (62.4) | 0.105 |
6‐week symptom improvement | 239/283 (84.5) | 216/266 (81.2) | 0.365 |
Abbreviations: BA, berberine and amoxicillin; TF, tetracycline and furazolidone.